Ketamine is a medication that was FDA approved in 1970 as an anesthetic and is on the World Health Organization’s list of essential medicines.  Since the early 2000’s, clinical trials involving ketamine have repeatedly demonstrated rapid improvement of Treatment-Resistant Depression.  Ketamine is unique among antidepressants in that it has a short onset of benefit for both Depression and Suicidal Ideation, often within hours.  Additionally, research shows that ketamine has neuroregenerative properties and can restore proper functioning between neural networks involved in depression.

With Ketamine Assisted Therapy, patients have the added advantage of receiving ketamine with support from a therapist who is trained to help them maximize benefit from each session.  Adding therapy to ketamine treatments allows people to make use of ketamine’s neuroplasticity effects to shift out of old patterns and perceptions for more enduring healing and transformation.  

Ketamine sessions are 90 minutes in length and take place twice per week for four weeks.  After this, you have the option to continue with a customized maintenance plan for ongoing support. 

For additional information about Ketamine Assisted Therapy, please visit our FAQ page.